Artificial Intelligence-Assisted Processing of Anterior Segment OCT Images in the Diagnosis of Vitreoretinal Lymphoma.

AI AS-OCT VRL anterior segment optical coherence tomography artificial intelligence machine learning radiomic features vitreoretinal lymphoma

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
23 Jul 2023
Historique:
received: 24 05 2023
revised: 19 07 2023
accepted: 20 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Anterior segment optical coherence tomography (AS-OCT) allows the explore not only the anterior chamber but also the front part of the vitreous cavity. Our cross-sectional single-centre study investigated whether AS-OCT can distinguish between vitreous involvement due to vitreoretinal lymphoma (VRL) and vitritis in uveitis. We studied AS-OCT images from 28 patients (11 with biopsy-proven VRL and 17 with differential diagnosis uveitis) using publicly available radiomics software written in MATLAB. Patients were divided into two balanced groups: training and testing. Overall, 3260/3705 (88%) AS-OCT images met our defined quality criteria, making them eligible for analysis. We studied five different sets of grey-level samplings (16, 32, 64, 128, and 256 levels), finding that 128 grey levels performed the best. We selected the five most effective radiomic features ranked by the ability to predict the class (VRL or uveitis). We built a classification model using the xgboost python function; through our model, 87% of eyes were correctly diagnosed as VRL or uveitis, regardless of exam technique or lens status. Areas under the receiver operating characteristic curves (AUC) in the 128 grey-level model were 0.95 [CI 0.94, 0.96] and 0.84 for training and testing datasets, respectively. This preliminary retrospective study highlights how AS-OCT can support ophthalmologists when there is clinical suspicion of VRL.

Identifiants

pubmed: 37510195
pii: diagnostics13142451
doi: 10.3390/diagnostics13142451
pmc: PMC10378347
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Prog Retin Eye Res. 2019 Sep;72:100761
pubmed: 31091471
BMC Ophthalmol. 2022 Jun 27;22(1):281
pubmed: 35761260
Front Neurosci. 2022 Oct 10;16:1012287
pubmed: 36300169
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Expert Rev Anti Infect Ther. 2006 Aug;4(4):675-85
pubmed: 17009945
Eye (Lond). 1987;1 ( Pt 2):254-62
pubmed: 3308528
Ocul Immunol Inflamm. 2021 May 19;29(4):786-795
pubmed: 34003716
Indian J Ophthalmol. 2016 May;64(5):369-75
pubmed: 27380976
Mol Imaging Biol. 2021 Apr;23(2):287-298
pubmed: 33030709
Clin Exp Ophthalmol. 2023 Mar;51(2):144-153
pubmed: 36567492
Insights Imaging. 2020 Aug 12;11(1):91
pubmed: 32785796
Cancers (Basel). 2022 May 31;14(11):
pubmed: 35681711
Prog Retin Eye Res. 2020 Nov;79:100847
pubmed: 32151758
Cancers (Basel). 2021 Aug 04;13(16):
pubmed: 34439078
Case Rep Ophthalmol. 2015 Sep 02;6(3):284-8
pubmed: 26483668
Br J Ophthalmol. 2019 Oct;103(10):1418-1422
pubmed: 30798264
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1154-1163
pubmed: 32286112
J Comput Assist Tomogr. 2021 Jul-Aug 01;45(4):629-636
pubmed: 34519454
Acta Ophthalmol. 2022 May;100(3):e820-e826
pubmed: 34219383
Med Biol Eng Comput. 2021 Feb;59(2):401-415
pubmed: 33492598
Br J Ophthalmol. 2019 Nov;103(11):1656-1659
pubmed: 30709808
Clin Radiol. 2004 Dec;59(12):1061-9
pubmed: 15556588
Retina. 2014 Jan;34(1):108-14
pubmed: 23619637
Retina. 2022 Aug 1;42(8):1433-1441
pubmed: 35333841
Neuroimage Clin. 2018;20:1070-1077
pubmed: 30366279
Am J Ophthalmol. 2023 Jan;245:134-144
pubmed: 36084686
Asia Pac J Ophthalmol (Phila). 2021 Jan 19;10(1):93-98
pubmed: 33481398
Curr Oncol. 2022 Jul 22;29(8):5179-5194
pubmed: 35892979
Retina. 2013 Mar;33(3):559-65
pubmed: 23042101
Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):860-70
pubmed: 14605902
Ocul Immunol Inflamm. 2023 Jul;31(5):1101-1102
pubmed: 35708306
Sci Rep. 2017 Aug 31;7(1):10117
pubmed: 28860628
Br J Ophthalmol. 2021 Aug;105(8):1155-1160
pubmed: 32816791
Neuro Oncol. 2017 Jun 1;19(6):862-870
pubmed: 28339588
Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1833-1841
pubmed: 34379571
Eur Radiol Exp. 2022 Sep 15;6(1):43
pubmed: 36104519
Invest Ophthalmol Vis Sci. 2021 Apr 1;62(4):31
pubmed: 33929483
Clin Ophthalmol. 2023 Jan 11;17:165-174
pubmed: 36660310
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Phys Med Biol. 2015 Jul 21;60(14):5471-96
pubmed: 26119045
JCO Clin Cancer Inform. 2022 Nov;6:e2200023
pubmed: 36332157
Oncotarget. 2017 Jan 31;8(5):7989-7998
pubmed: 28002793
Curr Opin Ophthalmol. 2005 Dec;16(6):356-63
pubmed: 16264346
Retina. 2014 Feb;34(2):366-72
pubmed: 23958842
Phys Med. 2017 Jun;38:122-139
pubmed: 28595812
Surv Ophthalmol. 2014 Sep-Oct;59(5):503-16
pubmed: 24560125
Br J Ophthalmol. 2018 Oct;102(10):1362-1366
pubmed: 29306864
Discov Med. 2013 Feb;15(81):93-100
pubmed: 23449111
BMC Med Imaging. 2020 Jul 6;20(1):75
pubmed: 32631330
Abdom Radiol (NY). 2021 Aug;46(8):3835-3844
pubmed: 33728532
Cancers (Basel). 2023 Mar 21;15(6):
pubmed: 36980760
Am J Ophthalmol. 2022 Jun;238:16-26
pubmed: 34843686
Ocul Immunol Inflamm. 2021 Apr 03;29(3):507-520
pubmed: 34009095
Ophthalmology. 2014 Sep;121(9):1706-14
pubmed: 24835759
Radiology. 1999 Nov;213(2):317-20
pubmed: 10551208
J Nucl Med. 2022 Feb;63(2):172-179
pubmed: 34531263
Sci Rep. 2019 Feb 14;9(1):2068
pubmed: 30765732
Ophthalmology. 2017 Nov;124(11):1670-1677
pubmed: 28625685
Am J Ophthalmol. 2009 May;147(5):886-94, 894.e1
pubmed: 19243734
Clin Exp Ophthalmol. 2023 Mar;51(2):107-109
pubmed: 36789671
Curr Oncol. 2022 Sep 24;29(10):6908-6921
pubmed: 36290820
Int J Retina Vitreous. 2022 Aug 26;8(1):58
pubmed: 36028905
Ultrasound Med Biol. 2017 May;43(5):1058-1069
pubmed: 28233619
Middle East Afr J Ophthalmol. 2009 Oct;16(4):239-44
pubmed: 20404990

Auteurs

Fabrizio Gozzi (F)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Marco Bertolini (M)

Medical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Pietro Gentile (P)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Laura Verzellesi (L)

Medical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Valeria Trojani (V)

Medical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Luca De Simone (L)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Elena Bolletta (E)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Valentina Mastrofilippo (V)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Enrico Farnetti (E)

Molecular Pathology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Davide Nicoli (D)

Molecular Pathology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Stefania Croci (S)

Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Lucia Belloni (L)

Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Alessandro Zerbini (A)

Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Chantal Adani (C)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Michele De Maria (M)

Ophthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Areti Kosmarikou (A)

Ophthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Marco Vecchi (M)

Ophthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Alessandro Invernizzi (A)

Eye Clinic, Luigi Sacco Hospital, Department of Biomedical and Clinical Science, University of Milan, 20157 Milan, Italy.
Faculty of Health and Medicine, Save Sight Institute, University of Sydney, Sydney, NSW 2000, Australia.

Fiorella Ilariucci (F)

Hematology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Magda Zanelli (M)

Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Mauro Iori (M)

Medical Physics Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.

Luca Cimino (L)

Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Classifications MeSH